These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38336493)

  • 1. Resident memory T cell contributes to the phenotype of inflammatory vitiligo.
    Okamura K; Kabasawa T; Saito T; Arai Y; Futakuchi M; Suzuki T
    J Dermatol Sci; 2024 Feb; 113(2):74-76. PubMed ID: 38336493
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery of resident memory T cells in inflammatory vitiligo: A case report.
    Xu Y; Zhang BX; Lin M; Zhang L
    Medicine (Baltimore); 2022 Oct; 101(41):e31007. PubMed ID: 36254016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is targeting circulating T blood cells a therapeutic option for vitiligo?
    Matos TR
    Br J Dermatol; 2020 Nov; 183(5):803. PubMed ID: 32458433
    [No Abstract]   [Full Text] [Related]  

  • 4. Resident memory T cells in nonlesional skin and healed lesions of patients with chronic inflammatory diseases: Appearances can be deceptive.
    Migayron L; Merhi R; Seneschal J; Boniface K
    J Allergy Clin Immunol; 2024 Mar; 153(3):606-614. PubMed ID: 37995858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitiligo as a skin memory disease: The need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells.
    Boniface K; Seneschal J
    Exp Dermatol; 2019 Jun; 28(6):656-661. PubMed ID: 30636075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3.
    Boniface K; Jacquemin C; Darrigade AS; Dessarthe B; Martins C; Boukhedouni N; Vernisse C; Grasseau A; Thiolat D; Rambert J; Lucchese F; Bertolotti A; Ezzedine K; Taieb A; Seneschal J
    J Invest Dermatol; 2018 Feb; 138(2):355-364. PubMed ID: 28927891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of Tissue Resident Memory T cells in vitiligo: From pathogenesis to therapeutics.
    Shah F; Patel S; Begum R; Dwivedi M
    Autoimmun Rev; 2021 Aug; 20(8):102868. PubMed ID: 34118458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Memory CD8
    Riding RL; Harris JE
    J Immunol; 2019 Jul; 203(1):11-19. PubMed ID: 31209143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype and function of circulating memory T cells in human vitiligo.
    Martins C; Darrigade AS; Jacquemin C; Barnetche T; Taieb A; Ezzedine K; Boniface K; Seneschal J
    Br J Dermatol; 2020 Nov; 183(5):899-908. PubMed ID: 32012221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin-resident memory T cells as a potential new therapeutic target in vitiligo and melanoma.
    Willemsen M; Linkutė R; Luiten RM; Matos TR
    Pigment Cell Melanoma Res; 2019 Sep; 32(5):612-622. PubMed ID: 31230406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocyte-specific CD49a
    Yokoi K; Watanabe R; Kume M; Yamane S; Tanaka A; Fujimoto M; Tanemura A
    J Dermatol; 2023 May; 50(5):710-714. PubMed ID: 36514908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resident Memory and Recirculating Memory T Cells Cooperate to Maintain Disease in a Mouse Model of Vitiligo.
    Richmond JM; Strassner JP; Rashighi M; Agarwal P; Garg M; Essien KI; Pell LS; Harris JE
    J Invest Dermatol; 2019 Apr; 139(4):769-778. PubMed ID: 30423329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-resident memory T cells in the skin.
    Khalil S; Bardawil T; Kurban M; Abbas O
    Inflamm Res; 2020 Mar; 69(3):245-254. PubMed ID: 31989191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy.
    Han J; Zhao Y; Shirai K; Molodtsov A; Kolling FW; Fisher JL; Zhang P; Yan S; Searles TG; Bader JM; Gui J; Cheng C; Ernstoff MS; Turk MJ; Angeles CV
    Nat Cancer; 2021 Mar; 2(3):300-311. PubMed ID: 34179824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CD49a+ CD8+ resident memory T cells in vitiligo-like lesions associated with nivolumab treatment for melanoma.
    Nakashima C; Ishida Y; Nakagawa K; Irie H; Hirata M; Kataoka T; Otsuka A; Kabashima K
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):e79-e82. PubMed ID: 31571305
    [No Abstract]   [Full Text] [Related]  

  • 16. Compromised melanocyte survival due to decreased suppression of CD4
    Shah F; Giri PS; Bharti AH; Dwivedi M
    Exp Dermatol; 2024 Jan; 33(1):e14982. PubMed ID: 37994568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.
    Richmond JM; Strassner JP; Zapata L; Garg M; Riding RL; Refat MA; Fan X; Azzolino V; Tovar-Garza A; Tsurushita N; Pandya AG; Tso JY; Harris JE
    Sci Transl Med; 2018 Jul; 10(450):. PubMed ID: 30021889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD49a Expression Defines Tissue-Resident CD8
    Cheuk S; Schlums H; Gallais Sérézal I; Martini E; Chiang SC; Marquardt N; Gibbs A; Detlofsson E; Introini A; Forkel M; Höög C; Tjernlund A; Michaëlsson J; Folkersen L; Mjösberg J; Blomqvist L; Ehrström M; Ståhle M; Bryceson YT; Eidsmo L
    Immunity; 2017 Feb; 46(2):287-300. PubMed ID: 28214226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma.
    Byrne KT; Zhang P; Steinberg SM; Turk MJ
    J Immunol; 2014 Feb; 192(4):1433-9. PubMed ID: 24403535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of T
    Frączek A; Owczarczyk-Saczonek A; Placek W
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.